NNovo Nordisk Read More Novo Nordisk Deploys Licensed Semaglutide Copy in South Africa While Waging Legal War on Two Fronts2026-07-27 The Danish drugmaker is fighting for its GLP-1 franchise on multiple fronts — from the courtroom to the…
NNovo Nordisk Read More Novo Nordisk Stages a Two-Front Offensive: Oral Wegovy Explodes in the US While China Beckons2026-06-19 Shares of Novo Nordisk surged more than 4% on Friday to 39.23 euros, as investors digested a barrage…
BBerlin Read More Spy war in Berlin: Russia, Iran, China and Turkey lead the way2026-06-19 18.06.2026 17:12 The German domestic intelligence report revealed that the most active foreign intelligence services in Berlin are…
NNovo Nordisk Read More Novo Nordisk’s Dual Challenge: Building Production Muscle While Proving Pipeline Might2026-06-04 Novo Nordisk stock down 47% as investors eye €1B Italy plant expansion and pivotal Phase 3 CagriSema data…
BBerlin Read More BioNTech’s Dual Burden: Advancing Oncology Trials While Navigating Berlin’s Vaccine Stockpile Fallou2026-06-04 BioNTech launches Phase 1/2 trial for Pumitamig in renal cancer while navigating 7.6M unused vaccine doses, a 25%…
NNovo Nordisk Read More Novo Nordisk Invests Billions in Buybacks While Expanding Heart-Disease Evidence2026-05-26 Novo Nordisk repurchases DKK 4.47bn in shares amid 38% stock drop, unveils POSEIDON study on residual inflammatory risk,…
NNovo Nordisk Read More Novo Nordisk Repurposes $1.3B Factory Into Warehouse While Zenagamtide Opens New Obesity Frontiers2026-05-17 Novo Nordisk abandons a $1.3B Odense plant for rare diseases, converting it to a warehouse as Wegovy and…